ResearchMoz

Avastin (Ovarian Cancer) Analysis and Forecasts to 2020

Publisher Name » GlobalData
Published Date » 2011-10-20
No. Of Pages » 35

Summary

GlobalDatas pharmaceuticals report, Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Avastin sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.

Scope
  • Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
  • Analysis and review of Avastin including sales data 
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Avastin including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Detailed sales forecast for 2012-2020 for Avastin in the seven major markets
Reasons to buy
  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance 
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of Contents

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Introduction 4
2.1 Ovarian Cancer 4
2.2 Ovarian Cancer Market 4
2.3 Epidemiology 4
2.4 Etiology 6
2.4.1 Age 6
2.4.2 Inherited Gene Mutations 6
2.4.3 A Previous Cancer Diagnosis 6
2.4.4 Early Menstruation or Late menopause 7
2.4.5 Family History of Ovarian Cancer 7
2.5 GlobalData Report Guidance 7

3 Ovarian Cancer: Market Characterization 8
3.1 Ovarian Cancer Market 8
3.2 Ovarian Cancer Market Forecasts and CAGR 8
3.3 Drivers for Ovarian Cancer Market 9
3.3.1 High Incidence 9
3.3.2 High Mortality Rate 10
3.3.3 Increased Use of Chemotherapy in Ovarian Cancer 11
3.3.4 Emergence of Targeted Drugs 11
3.3.5 Recurrence of Tumor 11
3.3.6 Low Initial Diagnosis Rate 11

4 Tumor-Node-Metastases (TNM) Classification of Ovarian Cancer 12

5 Avastin (bevacizumab) 15
5.1 Introduction 15
5.2 Mechanism of Action 15
5.3 Clinical Studies 15
5.3.1 First Line Trials 15
5.3.2 Second Line Trials 16
5.4 Approval History of Avastin 16
5.5 Factors Affecting Sales of Avastin 17
5.5.1 High Efficacy 17
5.5.2 Limited Treatment Options 17
5.5.3 Presence in Multiple Lines of Treatment 17
5.5.4 Wide Acceptance 17
5.6 Drug Evaluation 18
5.6.1 Drug Risk Benefit Score 18
5.6.2 Intensity of Competition 19
5.7 Sales Forecasts 19
5.7.1 Target Patient Pool of Avastin 19
5.7.2 Dosing 20
5.7.3 Market Penetration 20
5.7.4 Annual Cost of Therapy 21
5.7.5 Sales Forecasts of Avastin 22

6 Ovarian Cancer Market: Appendix 31
6.1 Market Definitions 31
6.2 List of Abberiviations 31
6.3 Research Methodology 31
6.3.1 Coverage 31
6.3.2 Secondary Research 32
6.3.3 Forecasting 32
6.3.4 Number of Patients Approved to take the Drug 32
6.3.5 Net Penetration of Drug 32
6.3.6 Net Annual Dosing 33
6.3.7 Annual Cost of Therapy 33
6.3.8 Primary Research 34
6.3.9 Expert Panels 34
6.4 Contact Us 34
6.5 Disclaimer 34
6.6 Sources 35

List of Tables


Table 1: Ovarian Cancer, Incidences and Mortality, 20082030 6
Table 2: Ovarian Cancer, Global, Market Size Forecasts ($m), 20092020 8
Table 3: Detailed TNM Classification 13
Table 4: Approval History of Avastin 16
Table 5: Drug Risk Benefit Score of Avastin 18
Table 6: Avastin, Ovarian Cancer, Global, Annual Cost of Therapy ($), 2012 21
Table 7: Avastin, Ovarian Cancer, Global, Sales Forecasts ($m), 20122020 22
Table 8: Avastin, Ovarian Cancer, The US, Sales Forecasts ($m), 20122020 23
Table 9: Avastin, Ovarian Cancer, The UK, Sales Forecasts ($m), 20122020 24
Table 10: Avastin, Ovarian Cancer, France, Sales Forecasts ($m), 20122020 25
Table 11: Avastin, Ovarian Cancer, Germany, Sales Forecasts ($m), 20122020 26
Table 12: Avastin, Ovarian Cancer, Italy, Sales Forecasts ($m), 20122020 27
Table 13: Avastin, Ovarian Cancer, Spain, Sales Forecasts ($m), 20122020 28
Table 14: Avastin, Ovarian Cancer, Japan, Sales Forecasts ($m), 20132020 29

List of Figures


Figure 1: Distribution by Incidence and Mortality, Most Commonly Diagnosed Cancers, Worldwide, 2010 5
Figure 2: Ovarian Cancer, Global, Market Size Forecasts ($m), 20092020 8
Figure 3: Ovarian Cancer, Worldwide, Incidence (in million), 2008-2030 9
Figure 4: Oncology, Worldwide, Incidence (in million), 2008-2030 10
Figure 5: Ovarian Cancer, Worldwide, Mortality (in million), 2008-2030 10
Figure 6: Broad Classification of Ovarian Cancer 12
Figure 7: Classification of Ovarian Cancer 14
Figure 8: Drug Model Diagram of Avastin 20
Figure 9: Avastin, Ovarian Cancer, Global, Sales Forecasts ($m), 20122020 22
Figure 10: Avastin, Ovarian Cancer, The US, Sales Forecasts ($m), 20122020 23
Figure 11: Avastin, Ovarian Cancer, The UK, Sales Forecasts ($m), 20122020 24
Figure 12: Avastin, Ovarian Cancer, France, Sales Forecasts ($m), 20122020 25
Figure 13: Avastin, Ovarian Cancer, Germany, Sales Forecasts ($m), 20122020 26
Figure 14: Avastin, Ovarian Cancer, Italy, Sales Forecasts ($m), 20122020 27
Figure 15: Avastin, Ovarian Cancer, Spain, Sales Forecasts ($m), 20122020 28
Figure 16: Avastin, Ovarian Cancer, Japan, Sales Forecasts ($m), 20132020 29
Figure 17: Avastin, Ovarian Cancer, Global, Sales Distribution (%), 2018 30
Figure 18: Drug Model Diagram 33
Figure 19: Patients Approved for the Drug 33

Upcoming Reports:

Silicone Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth, And Forecast, 2012 - 2018
By - Transparency Market Research
Silicones are synthetic compounds which are used most widely in applications such as sealants, adhesives, insulation, medical applications and lubricants owing to their excellent heat resistance and rubber like quality. Silicones are basically polymers that contain silicon along with carbon, oxygen and hydrogen.  Asia-Pacific is the leading market for silicones both in terms of production and consumption followed by North America and Europe. Asia-Pacific accounted for over 40% of the global market in 2011. . China, with growing household and disposable income, is the most...
Wireless High Definition (HD) Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The global wireless HD market has shown remarkable progress in the recent years and is also showing good market potential in the future. A wireless HD is used in many applications such as in medicine, industrial processes, and consumer electronics. Some of the recent applications of wireless HD are portable media players and portable gaming devices, HD camcorders, and 3G/4G mobile communications handsets. The global wireless HD market is driven by factors such as emerging technological developments and increasing penetration in emerging economies. The launch of new...
Flow Sensors Technology Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012 - 2018
By - Transparency Market Research
Flow sensors are devices which are used for measuring the flow of liquid, gases, viscous media, solid materials and steam. There are several industries that use flow sensors such as discrete manufacturing industries, process industries, automotive industries, aircraft industries, and medical and construction sectors. Automotive industries and process industries are the leading markets for the usage of flow sensor devices.  Introduction of smart functions and various other technologies such as self diagnosis capability, microcontrollers, and remote two way communication...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...